Devyser and Thermo Fisher Scientific collaborate to promote laboratory services to advance pharmaceutical research
Devyser and Thermo Fisher Scientific have entered into a collaboration agreement to promote...
Thalassemias | October 3, 2022
Causes
Thalassemias are haemoglobinopathies characterised by an abnormal haemoglobin production that can lead to anaemia and destruction of red blood cells. Alpha and beta thalassemia, the two main types of thalassemia, are caused by inadequate production of the α and/or ß globin molecule.
Symptoms
Symptoms of thalassemia vary from mild, to severe and even fatal. In 1990 more than 36,000 deaths were reported due to thalassemia. This has decreased to 16,800 in 2015 primarily due to national screening programs and family planning. Approximately 5% of the global population has a variant in the genes coding for the alpha or beta haemoglobin molecules. Of these, 34% have symptoms.
Prevalence
Alpha thalassemia is most common in sub-tropical and tropical areas. In certain ethnic groups, the prevalence can be as high as 30%, with up to 90% as carriers. Beta thalassaemia is particularly prevalent among the Mediterranean, African and South Asian population. It is hypothesised that alpha and beta thalassemia are more prevalent in malaria exposed regions due to improved disease protection.
